Report overview
Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.
This report aims to provide a comprehensive presentation of the global market for Anti-Suicide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Suicide Drugs. This report contains market size and forecasts of Anti-Suicide Drugs in global, including the following market information:
Global Anti-Suicide Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Suicide Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Suicide Drugs companies in 2022 (%)
The global Anti-Suicide Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anti-Depressants and Anti-Anxiety Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Suicide Drugs include Pfizer, Inc, AstraZeneca Plc, Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc, H. Lundbeck A/S, NeuroRx, Inc and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Suicide Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Suicide Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Suicide Drugs Market Segment Percentages, by Type, 2022 (%)
Anti-Depressants and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Global Anti-Suicide Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Suicide Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Retail Pharmacies
Online Pharmacies
Global Anti-Suicide Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Suicide Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Suicide Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Suicide Drugs revenues share in global market, 2022 (%)
Key companies Anti-Suicide Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Suicide Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc
AstraZeneca Plc
Eli Lilly and Company
Allergan Plc
GlaxoSmithKline Plc
Merck & Co., Inc
H. Lundbeck A/S
NeuroRx, Inc
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Suicide Drugs, market overview.
Chapter 2: Global Anti-Suicide Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Suicide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Suicide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Suicide Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
